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Introduction. The role of radiotherapy (RT) after breast-conserving surgery (BCS) in ductal carcinoma in situ (DCIS) has been well
established after 4 randomized trials in decreasing local recurrence rate, but its use still remains controversial.
Objectives. We study the DCIS features and treatment modalities in Catalonia (C) and we compare them with the French (F)
experience for the similar prognostic patients sub-groups.
Methods. Cases were compared according to prognosis factors and therapeutic procedures. Both cohorts were observational and
prospective. The period studied was from March 2003 to April 2004 (n=1289 from 77 hospitals) in F and during all 2005 (n=250
from 12 centres) in C (only 2 centres reported the M).
Results. The median age was similar in both cohorts (57a). MRI was applied in 16% of the cases in C and not available in F. High
nuclear grade was 57.5% in C vs 40.5% in F (p<0.05). Median tumour size was 15.8mm, 37.5mm in mastectomy (M) in C and
14.5mm, 35mm in M in F (p>0.05). Comedonecrosis presence was 54% in C and 24% in F (p<0.05). Free-margins (≥3mm) were
30.6% in C and 38.3% in F (p>0.05). Surgery modalities: M in C 11% vs 30.5% in F (p<0.05). BCS 89% in C vs 69.5% in F (p<0.05).
BCS+RT 78% in C vs 62% in F (p<0.05). Boost 49% in C vs 53% in F (p<0.05). Immediate reconstruction (IR): 42% in C (83%<50y) vs
55% in F (80%<40y) (p<0.05). Oestrogen receptor (ER) evaluation: 75% in C vs 31% in F (p<0.05). ER+74% in C vs 70% in F (p>0.05).
Hormonotherapy 51% in C vs 13% in F (p<0.05).
Conclusions. The DCIS management in Catalonia differs from France in MRI use, frequency of M (data obtained bias in C), more
proportion of BCS and BCS+RT in C even more boost in F although unfavourable histological factors in C. When M was applied
the use of IR is more frequent in F. ER determination was more frequent in C and even the hormonotherapy.
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